Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties
Publication
, Conference
Michael, ZD; Kotamarti, S; Arcot, R; Morris, K; Shah, A; Anderson, J; Armstrong, A; Gupta, R; Preminger, GM; Moul, JW; Oeffinger, K; Shah, K ...
Published in: EUROPEAN UROLOGY
2022
Duke Scholars
Published In
EUROPEAN UROLOGY
EISSN
1873-7560
ISSN
0302-2838
Publication Date
2022
Volume
81
Start / End Page
S567 / S568
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Michael, Z. D., Kotamarti, S., Arcot, R., Morris, K., Shah, A., Anderson, J., … Polascik, T. J. (2022). Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties. In EUROPEAN UROLOGY (Vol. 81, pp. S567–S568).
Michael, Z. D., S. Kotamarti, R. Arcot, K. Morris, A. Shah, J. Anderson, A. Armstrong, et al. “Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties.” In EUROPEAN UROLOGY, 81:S567–68, 2022.
Michael ZD, Kotamarti S, Arcot R, Morris K, Shah A, Anderson J, et al. Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties. In: EUROPEAN UROLOGY. 2022. p. S567–8.
Michael, Z. D., et al. “Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties.” EUROPEAN UROLOGY, vol. 81, 2022, pp. S567–68.
Michael ZD, Kotamarti S, Arcot R, Morris K, Shah A, Anderson J, Armstrong A, Gupta R, Preminger GM, Moul JW, Oeffinger K, Shah K, Polascik TJ. Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties. EUROPEAN UROLOGY. 2022. p. S567–S568.
Published In
EUROPEAN UROLOGY
EISSN
1873-7560
ISSN
0302-2838
Publication Date
2022
Volume
81
Start / End Page
S567 / S568
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences